Testing effectiveness (Phase 2)Ended earlyNCT02702115
What this trial is testing
Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I
Who this might be right for
MPS I
Sangamo Therapeutics 3